Medscape Hematology-Oncology Headlines

ASCO 2009: Oncology Insights

Thu, 2 Jul 2009 14:33:49 EDT

In this fascinating exclusive video interview, Dr. Maurie Markman talks with Dr. David Alberts about some of the greatest challenges facing oncologists in the current environment.
Medscape Hematology-Oncology

HPV Vaccination Is Not Cost-Effective in the Netherlands

Thu, 2 Jul 2009 09:59:14 EDT

Even under the most favorable assumptions, the HPV vaccine was not found to be cost effective, Dutch researchers report.
Medscape Medical News

Cancer Patients Undertreated for VTE, Despite Guideline Recommendations

Thu, 2 Jul 2009 09:19:01 EDT

Many oncology patients do not receive appropriate VTE prophylaxis as recommended by practice guidelines, despite the high rates of associated morbidity and mortality.
Medscape Medical News

Pilot Study First to Offer Online Testing for Lung Cancer Gene Variant

Thu, 2 Jul 2009 07:43:42 EDT

All participants at higher risk for lung cancer interpreted the results correctly compared with 55% of those in the lower-risk group.
Medscape Medical News

PET-CT Is Better for Preoperative Staging of Lung Cancer

Wed, 1 Jul 2009 17:40:30 EDT

Use of PET-CT preoperatively provides a number of advantages over conventional staging in lung cancer patients.
Medscape Medical News

Insulin Glargine Potentially Associated With Increased Cancer Risk

Wed, 1 Jul 2009 16:52:02 EDT

The increased risk has been seen in 3 of 4 observational studies, but these findings warrant further follow-up studies to confirm an association, according to the FDA.
Medscape Medical News

Prostate Cancer Patients Should Not Take Selenium Supplements

Wed, 1 Jul 2009 15:02:31 EDT

Higher blood levels of selenium were associated with aggressive prostate cancer, particularly in men with a certain variant of the superoxide dismutase gene.
Medscape Medical News

Congressional Committee Hears of "Erratic" Placement of Radiation Seeds in Prostate Cancer Patients

Wed, 1 Jul 2009 14:06:58 EDT

Implantation of radiation seeds for the treatment of prostate cancer at 1 center in Philadelphia was "substandard," but this appears to be an isolated situation.
Medscape Medical News

FDA Safety Changes: Prevpac, Arava, Treanda

Wed, 1 Jul 2009 13:05:50 EDT

The FDA has approved safety labeling revisions for a prepackaged regimen of lansoprazole, amoxicillin, and clarithromycin tablets; leflunomide tablets; and bendamustine HCl intravenous infusion.
Medscape Medical News

New Hemoglobin Target Levels in Chronic Kidney Disease Suggested

Wed, 1 Jul 2009 12:39:29 EDT

A meta-analysis shows that targeting hemoglobin levels higher than 12.0 g/dL leads to small and not clinically meaningful improvements in health-related quality of life, despite safety concerns.
Medscape Medical News

Oncology Practice By “Paparazzi”?

Wed, 1 Jul 2009 09:51:10 EDT

Commenting on the frenzy created by short news cycles and anxious patients, Dr. John Marshall cautions oncologists to use critical thinking when evaluating newly reported data.
Medscape Hematology-Oncology

Risk for Pancreatic Cancer Increased by Early-Adulthood Obesity and Dietary Fat of Animal Origin

Tue, 30 Jun 2009 08:49:32 EDT

Two new studies provide details on how obesity and animal fats increase the risk for pancreatic cancer, and may offer new insight into pancreatic tumorigenesis.
Medscape Medical News

Effectiveness of Cultivando La Salud: A Breast and Cervical Cancer Screening Promotion Program for Low-Income Hispanic Women

Mon, 29 Jun 2009 18:41:14 EDT

How effectively could a lay health worker-delivered educational intervention increase breast and cervical cancer screening among low-income Hispanic women who did not adhere to recommended guidelines?
American Journal of Public Health

Massive Vitamin-D/Omega-3 Trial for CVD, Cancer Prevention

Mon, 29 Jun 2009 17:56:05 EDT

Study participants will be randomized to one of four groups: daily vitamin D (2000 IU) and fish oil (1 g); daily vitamin D and fish-oil placebo; daily vitamin-D placebo and fish oil; or daily vitamin-D placebo and fish-oil placebo and followed for five years.
Heartwire

ASCO 2009: Expert Video Perspective on Prostate Cancer

Mon, 29 Jun 2009 15:53:27 EDT

Find out why Dr. Christopher Logothetis reports that we are on the "threshold of major change" in our understanding of prostate cancer, in this report from ASCO 2009.
Medscape Hematology-Oncology

ASCO 2009: Expert Video Perspective on Lymphoma

Mon, 29 Jun 2009 15:53:13 EDT

In this video highlight, Dr. James Armitage shares his thoughts on the latest advances in lymphoma research from the 2009 ASCO annual meeting.
Medscape Hematology-Oncology

ASCO 2009: Expert Video Perspective on Multiple Myeloma

Mon, 29 Jun 2009 10:21:22 EDT

In this video highlight, Dr. Sagar Lonial shares his thoughts on the latest advances in multiple myeloma research from the 2009 ASCO annual meeting.
Medscape Hematology-Oncology

ASCO 2009: Expert Video Perspective on Renal Cancer

Mon, 29 Jun 2009 10:21:07 EDT

In this video editorial, Dr. Timothy M. Kuzel shares his thoughts on the latest advances in renal cancer treatments presented at the 2009 ASCO annual meeting.
Medscape Hematology-Oncology

Cancer Risk in Schizophrenia Needs More Attention

Fri, 26 Jun 2009 10:29:59 EDT

People with schizophrenia are 50% more likely to die of cancer than people in the general population.
Medscape Medical News

5α-Reductase Inhibitor Treatment of Prostatic Diseases: Background and Practical Implications

Wed, 1 Jul 2009 18:43:46 EDT

This literature review discusses the theoretical background of 5 alt=alpha minmax_bound=true>-reductase inhibitor (5ARI) treatment for prostatic diseases, and the resulting clinical implications.
Prostate Cancer and Prostatic Diseases